Ali İrfan Emre Tekgündüz

Prof. Dr. Ali İrfan Emre Tekgündüz is a prominent hematology expert recognized for his significant contributions to understanding and treating blood cancers. He has emphasized the importance of advancements in genetic and molecular testing, which enable personalized treatment plans for patients, marking a shift from one-size-fits-all approaches to tailored therapies. His research highlights the increasing incidence of hematological cancers due to various factors, including genetic predisposition and environmental exposures, while also pointing out the decline in mortality rates thanks to improved diagnostic and treatment methods. Recently, he was in the news for discussing the impact of innovative therapies, such as targeted and CAR-T cell treatments, which have made previously deadly cancers manageable.